H.J.P Fokkenrood

Innovative strategies for
intermittent claudication

towards a stepped care approach and new outcome measures



  1.  Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013.
  2.  Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998;18:185-92.
  3.  Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45 Suppl S:S5-67.
  4.  Anderson JL, Halperin JL, Albert NM, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:1425-43.
  5.  Layden J, Michaels J, Bermingham S, Higgins B, Guideline Development G. Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance. Bmj 2012;345:e4947.
  6.  Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Bmj 2002;324:71-86.
  7.  Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev 2006:CD005263.
  8.  Fakhry F, van de Luijtgaarden KM, Bax L, et al. Supervised walking therapy in patients with intermittent claudication. J Vasc Surg 2012;56:1132-42.
  9.  Nicolai SP, Teijink JA, Prins MH. Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication. J Vasc Surg 2010;52:348-55.
  10.  Wind J, Koelemay MJ. Exercise therapy and the additional effect of supervision on exercise therapy in patients with intermittent claudication. Systematic review of randomised controlled trials. Eur J Vasc Endovasc Surg 2007;34:1-9.
  11.  Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation 2012;125:130-9.
  12.  Makris GC, Lattimer CR, Lavida A, Geroulakos G. Availability of supervised exercise programs and the role of structured home-based exercise in peripheral arterial disease. Eur J Vasc Endovasc Surg 2012;44:569-75; discussion 76.
  13.  Shalhoub J, Hamish M, Davies AH. Supervised exercise for intermittent claudication - an under-utilised tool. Annals of the Royal College of Surgeons of England 2009;91:473-6.
  14.  Bermingham SL, Sparrow K, Mullis R, et al. The Cost-effectiveness of Supervised Exercise for the Treatment of Intermittent Claudication. Eur J Vasc Endovasc Surg 2013;46:707-14.
  15.  Mazari FA, Khan JA, Carradice D, et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. Br J Surg 2013;100:1172-9.
  16.  O'Brien-Irr MS, Harris LM, Dosluoglu HH, Dryjski ML. Endovascular intervention for treatment of claudication: is it cost-effective? Annals of vascular surgery 2010;24:833-40.
  17.  Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial. J Vasc Surg 2008;48:1472-80.
  18.  Treesak C, Kasemsup V, Treat-Jacobson D, Nyman JA, Hirsch AT. Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease. Vasc Med 2004;9:279-85.
  19.  Treesak Asselt AD, Nicolai SP, Joore MA, Prins MH, Teijink JA. Cost-effectiveness of exercise therapy in patients with intermittent claudication: supervised exercise therapy versus a 'go home and walk' advice. Eur J Vasc Endovasc Surg 2011;41:97-103.
  20.  Mays RJ, Regensteiner JG. Therapy for peripheral artery disease: gaps in treating patients with claudication. Circulation 2014;130:929-31.
  21.  Galea MN, Weinman JA, White C, Bearne LM. Do behaviour-change techniques contribute to the effectiveness of exercise therapy in patients with intermittent claudication? A systematic review. Eur J Vasc Endovasc Surg 2013;46:132-41.
  22.  Popplewell MA, Bradbury AW. Why Do Health Systems Not Fund Supervised Exercise Programmes for Intermittent Claudication? Eur J Vasc Endovasc Surg 2014.
  23.  Lauret GJ, van Dalen HC, Hendriks HJ, et al. When is supervised exercise therapy considered useful in peripheral arterial occlusive disease? A nationwide survey among vascular surgeons. Eur J Vasc Endovasc Surg 2012;43:308-12.
  24.  Heran BS, Chen JM, Ebrahim S, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011:CD001800.
  25.  Rapport "De zorg: hoeveel extra is het ons waard? Dutch Ministry of Health Welfare and Sports.
  26.  Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:e463-654.
  27.  Tilloy E, Montaye M, Kee F, et al. Contribution of cardiovascular risk factors to coronary risk in patients with intermittent claudication in the PRIME Cohort Study of European men. Atherosclerosis 2009;206:563-8.
  28.  Willigendael EM, Bendermacher BL, van der Berg C, et al. The development and implementation of a regional network of physiotherapists for exercise therapy in patients with peripheral arterial disease, a preliminary report. BMC Health Serv Res 2005;5:49.
  29.  Bendermacher BL, Willigendael EM, Nicolai SP, et al. Supervised exercise therapy for intermittent claudication in a community-based setting is as effective as clinic-based. J Vasc Surg 2007;45:1192-6.
  30.  Lauret GJ, Gijsbers HJ, Hendriks EJ, Bartelink ML, de Bie RA, Teijink JA. The ClaudicatioNet concept: design of a national integrated care network providing active and healthy aging for patients with intermittent claudication. Vasc Health Risk Manag 2012;8:495-503.
  31.  Creasy TS, McMillan PJ, Fletcher EW, Collin J, Morris PJ. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. European journal of vascular surgery 1990;4:135-40.
  32.  Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training--randomized controlled trial. Radiology 2009;250:586-95.
  33.  Ahimastos AA, Pappas EP, Buttner PG, Walker PJ, Kingwell BA, Golledge J. A meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication. J Vasc Surg 2011;54:1511-21.
  34.  Fakhry F, Rouwet EV, den Hoed PT, Hunink MG, Spronk S. Long-term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. Br J Surg 2013;100:1164-71.
  35.  Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM, Investigators V. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis vs bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg 2013.
  36.  Jongkind V, Akkersdijk GJ, Yeung KK, Wisselink W. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg 2010;52:1376-83.
  37.  Lensvelt MM, Reijnen MM, Wallis De Vries BM, Zeebregts CJ. Treatment strategies for extensive chronic SFA occlusions: indications and results. The Journal of cardiovascular surgery 2012;53:161-70.
  38.  Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med 2002;347:1941-51.
  39.  Kruidenier LM, Nicolai SP, Hendriks EJ, Bollen EC, Prins MH, Teijink JA. Supervised exercise therapy for intermittent claudication in daily practice. J Vasc Surg 2009;49:363-70.
  40.  Watson  CJ, Phillips D, Hands L, Collin J. Claudication distance is poorly estimated and inappropriately measured. Br J Surg 1997;84:1107-9.
  41.  Frans FA, Zagers MB, Jens S, Bipat S, Reekers JA, Koelemay MJ. The relationship of walking distances estimated by the patient, on the corridor and on a treadmill, and the Walking Impairment Questionnaire in intermittent claudication. J Vasc Surg 2013;57:720-7 e1.
  42.  Tew G, Copeland R, Le Faucheur A, Gernigon M, Nawaz S, Abraham P. Feasibility and validity of self-reported walking capacity in patients with intermittent claudication. Journal of vascular surgery 2013;57:1227-34.
  43.  Nordanstig J, Broeren M, Hensater M, Perlander A, Osterberg K, Jivegard L. Six-minute walk test closely correlates to "real-life" outdoor walking capacity and quality of life in patients with intermittent claudication. J Vasc Surg 2014;60:404-9.
  44.  McDermott MM, Ades PA, Dyer A, Guralnik JM, Kibbe M, Criqui MH. Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg 2008;48:1231-7, 7 e1.
  45.  Le Faucheur A, Abraham P, Jaquinandi V, Bouye P, Saumet JL, Noury-Desvaux B. Measurement of walking distance and speed in patients with peripheral arterial disease: a novel method using a global positioning system. Circulation 2008;117:897-904.
  46.  Nicolai SP, Viechtbauer W, Kruidenier LM, Candel MJ, Prins MH, Teijink JA. Reliability of treadmill testing in peripheral arterial disease: a meta-regression analysis. J Vasc Surg 2009;50:322-9.
  47.  Murphy TP, Reynolds MR, Cohen DJ, et al. Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication. J Vasc Interv Radiol 2013;24:1427-35; quiz 36.
  48.  Grontved A, Hu FB. Television viewing and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a meta-analysis. Jama 2011;305:2448-55.
  49.  Katzmarzyk PT. Physical activity, sedentary behavior, and health: paradigm paralysis or paradigm shift? Diabetes 2010;59:2717-25.
  50.  Katzmarzyk PT. Standing and Mortality in a Prospective Cohort of Canadian Adults. Med Sci Sports Exerc 2013.
  51.  Maher C, Olds T, Mire E, Katzmarzyk PT. Reconsidering the sedentary behaviour paradigm. PloS one 2014;9:e86403.
  52.  Thorp AA, Owen N, Neuhaus M, Dunstan DW. Sedentary behaviors and subsequent health outcomes in adults a systematic review of longitudinal studies, 1996-2011. American journal of preventive medicine 2011;41:207-15.
  53.  van der Ploeg HP, Chey T, Korda RJ, Banks E, Bauman A. Sitting time and all-cause mortality risk in 222 497 Australian adults. Arch Intern Med 2012;172:494-500.
  54.  Wilmot EG, Edwardson CL, Achana FA, et al. Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia 2012;55:2895-905.
  55.  Criqui MH. Systemic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease. The American journal of cardiology 2001;88:43J-7J.
  56.  Criqui MHL, R. D.; Fronek, A. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:7.
  57.  Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. Jama 2009;301:2024-35.
  58.  Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
  59.  Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007;116:1094-105.
  60.  Dijkstra B, Kamsma Y, Zijlstra W. Detection of gait and postures using a miniaturised triaxial accelerometer-based system: accuracy in community-dwelling older adults. Age and ageing 2010;39:259-62.
  61.  Dijkstra B, Kamsma YP, Zijlstra W. Detection of gait and postures using a miniaturized triaxial accelerometer-based system: accuracy in patients with mild to moderate Parkinson's disease. Archives of physical medicine and rehabilitation 2010;91:1272-7.
  62.   Dijkstra B , Zijlstra W, Scherder E, Kamsma Y. Detection of walking periods and number of steps in older adults and patients with Parkinson's disease: accuracy of a pedometer and an accelerometry-based method. Age and ageing 2008;37:436-41.
  63.  Langer D, Gosselink R, Sena R, Burtin C, Decramer M, Troosters T. Validation of two activity monitors in patients with COPD. Thorax 2009;64:641-2.
  64.  Kanda M, Minakata Y, Matsunaga K, et al. Validation of the triaxial accelerometer for the evaluation of physical activity in Japanese patients with COPD. Intern Med 2012;51:369-75.
  65.  Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Archives of physical medicine and rehabilitation 2005;86:1979-85.
  66.  Regensteiner JG, Hiatt WR, Coll JR, et al. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med 2008;13:15-24.
  67.  Dumville JC, Lee AJ, Smith FB, Fowkes FG. The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study. The British journal of general practice : the journal of the Royal College of General Practitioners 2004;54:826-31.
  68.  Brach JS, FitzGerald S, Newman AB, et al. Physical activity and functional status in community-dwelling older women: a 14-year prospective study. Arch Intern Med 2003;163:2565-71.
  69.  Nguyen HQ, Ackermann RT, Maciejewski M, et al. Managed-Medicare health club benefit and reduced health care costs among older adults. Preventing chronic disease 2008;5:A14.
  70.  Gardner AW, Womack CJ, Sieminski DJ, Montgomery PS, Killewich LA, Fonong T. Relationship between free-living daily physical activity and ambulatory measures in older claudicants. Angiology 1998;49:327-37.
  71.  Sieminski DJ, Gardner AW. The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease. Vasc Med 1997;2:286-91.
  72.  Crowther RG, Spinks WL, Leicht AS, Sangla K, Quigley F, Golledge J. Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease. J Vasc Surg 2008;47:303-9.
  73.  Lauret  GJ, Fokkenrood HJ, Bendermacher BL, Scheltinga MR, Teijink JA. Physical activity monitoring in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2014;47:656-63.
  74.  Gardner AW, Montgomery PS, Parker DE. Optimal exercise program length for patients with claudication. J Vasc Surg 2012;55:1346-54.
  75.  Gardner  AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation 2011;123:491-8.
  76.  Hiatt WR, Creager MA, Amato A, Brass EP. Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease. Journal of cardiopulmonary rehabilitation and prevention 2011;31:125-32.
  77.  McDermott MM, Liu K, Guralnik JM, et al. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. Jama 2013;310:57-65.
  78.  Rejeski WJ, Spring B, Domanchuk K, et al. A group-mediated, home-based physical activity intervention for patients with peripheral artery disease: effects on social and psychological function. Journal of translational medicine 2014;12:29.
  79.  Nordanstig  J, Taft C, Hensater M, Perlander A, Osterberg K, Jivegard L. Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation 2014;130:939-47.
  80.  Kinlay S. Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease. Circulation 2013;127:1241-50.
  81.  Lauret GJ, Fakhry F, Fokkenrood HJ, Hunink MG, Teijink JA, Spronk S. Modes of exercise training for intermittent claudication. Cochrane Database Syst Rev 2014;7:CD009638.
  82.  Collins TC, Lunos S, Carlson T, et al. Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease: a randomized controlled trial. Diabetes care 2011;34:2174-9.
  83.  Regensteiner JG, Meyer TJ, Krupski WC, Cranford LS, Hiatt WR. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology 1997;48:291-300.
  84.  Gommans LN, Saarloos R, Scheltinga MR, et al. Editor's Choice - The Effect of Supervision on Walking Distance in Patients with Intermittent Claudication: A Meta-analysis. Eur J Vasc Endovasc Surg 2014;48:169-84.